These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 9748358)
21. Characterization of melatonin receptors in the brain of four avian species: duck, goose, pigeon, and turkey. Zawilska JB; Nowak JZ Gen Comp Endocrinol; 1996 Feb; 101(2):227-34. PubMed ID: 8812381 [TBL] [Abstract][Full Text] [Related]
22. 3D QSAR comparative molecular field analysis on nonsteroidal farnesoid X receptor activators. Honório KM; Garratt RC; Polikarpov I; Andricopulo AD J Mol Graph Model; 2007 Mar; 25(6):921-7. PubMed ID: 17055759 [TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of benzoxazole derivatives as novel melatoninergic ligands. Sun LQ; Chen J; Takaki K; Johnson G; Iben L; Mahle CD; Ryan E; Xu C Bioorg Med Chem Lett; 2004 Mar; 14(5):1197-200. PubMed ID: 14980664 [TBL] [Abstract][Full Text] [Related]
24. A comparative molecular field analysis (CoMFA) study using semiempirical, density functional, ab initio methods and pharmacophore derivation using DISCOtech on sigma 1 ligands. Jung D; Floyd J; Gund TM J Comput Chem; 2004 Aug; 25(11):1385-99. PubMed ID: 15185333 [TBL] [Abstract][Full Text] [Related]
25. Semipreparative enantiomeric separation of a series of putative melatonin receptor agents using tri-acetylcellulose as chiral stationary phase. Jansen JM; Copinga S; Gruppen G; Isaksson R; Witte DT; Grol CJ Chirality; 1994; 6(7):596-604. PubMed ID: 7986673 [TBL] [Abstract][Full Text] [Related]
27. Arylpiperazines with serotonin-3 antagonist activity: a comparative molecular field analysis. Morreale A; Gálvez-Ruano E; Iriepa-Canalda I; Boyd DB J Med Chem; 1998 Jun; 41(12):2029-39. PubMed ID: 9622544 [TBL] [Abstract][Full Text] [Related]
28. Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models. Gaillard P; Carrupt PA; Testa B; Schambel P J Med Chem; 1996 Jan; 39(1):126-34. PubMed ID: 8568799 [TBL] [Abstract][Full Text] [Related]
29. Synthesis, biochemical evaluation, and classical and three-dimensional quantitative structure-activity relationship studies of 7-substituted-1,2,3,4-tetrahydroisoquinolines and their relative affinities toward phenylethanolamine N-methyltransferase and the alpha2-adrenoceptor. Grunewald GL; Dahanukar VH; Jalluri RK; Criscione KR J Med Chem; 1999 Jan; 42(1):118-34. PubMed ID: 9888838 [TBL] [Abstract][Full Text] [Related]
30. Comparative molecular field analysis of flavonoid inhibitors of the PIM-1 kinase. Holder S; Lilly M; Brown ML Bioorg Med Chem; 2007 Oct; 15(19):6463-73. PubMed ID: 17637507 [TBL] [Abstract][Full Text] [Related]
31. A rhodopsin-based model for melatonin recognition at its G protein-coupled receptor. Navajas C; Kokkola T; Poso A; Honka N; Gynther J; Laitinen JT Eur J Pharmacol; 1996 May; 304(1-3):173-83. PubMed ID: 8813600 [TBL] [Abstract][Full Text] [Related]
32. Diltiazem-like calcium entry blockers: a hypothesis of the receptor-binding site based on a comparative molecular field analysis model. Corelli F; Manetti F; Tafi A; Campiani G; Nacci V; Botta M J Med Chem; 1997 Jan; 40(1):125-31. PubMed ID: 9016337 [TBL] [Abstract][Full Text] [Related]
33. Comparative molecular field analysis of a series of paclitaxel analogues. Zhu Q; Guo Z; Huang N; Wang M; Chu F J Med Chem; 1997 Dec; 40(26):4319-28. PubMed ID: 9435901 [TBL] [Abstract][Full Text] [Related]
34. Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity. Anzini M; Canullo L; Braile C; Cappelli A; Gallelli A; Vomero S; Menziani MC; De Benedetti PG; Rizzo M; Collina S; Azzolina O; Sbacchi M; Ghelardini C; Galeotti N J Med Chem; 2003 Aug; 46(18):3853-64. PubMed ID: 12930147 [TBL] [Abstract][Full Text] [Related]
35. Predictive models for GABAA/benzodiazepine receptor subtypes: studies of quantitative structure-activity relationships for imidazobenzodiazepines at five recombinant GABAA/benzodiazepine receptor subtypes [alphaxbeta3gamma2 (x = 1-3, 5, and 6)] via comparative molecular field analysis. Huang Q; Liu R; Zhang P; He X; McKernan R; Gan T; Bennett DW; Cook JM J Med Chem; 1998 Oct; 41(21):4130-42. PubMed ID: 9767648 [TBL] [Abstract][Full Text] [Related]
36. Studies of molecular pharmacophore/receptor models for GABAA/benzodiazepine receptor subtypes: binding affinities of substituted beta-carbolines at recombinant alpha x beta 3 gamma 2 subtypes and quantitative structure-activity relationship studies via a comparative molecular field analysis. Huang Q; Cox ED; Gan T; Ma C; Bennett DW; McKernan RM; Cook JM Drug Des Discov; 1999 Jul; 16(1):55-76. PubMed ID: 10466057 [TBL] [Abstract][Full Text] [Related]
37. Quantitative structure-activity relationships within a series of melatonin analogs and related indolealkylamines. Lewis DF; Arendt J; English J J Pharmacol Exp Ther; 1990 Jan; 252(1):370-3. PubMed ID: 2153808 [TBL] [Abstract][Full Text] [Related]
38. 3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA. Doddareddy MR; Jung HK; Cha JH; Cho YS; Koh HY; Chang MH; Pae AN Bioorg Med Chem; 2004 Apr; 12(7):1613-21. PubMed ID: 15028254 [TBL] [Abstract][Full Text] [Related]
39. Comparative molecular field analysis of hydantoin binding to the neuronal voltage-dependent sodium channel. Brown ML; Zha CC; Van Dyke CC; Brown GB; Brouillette WJ J Med Chem; 1999 May; 42(9):1537-45. PubMed ID: 10229624 [TBL] [Abstract][Full Text] [Related]
40. QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor. Zhang H; Li H; Ma Q J Mol Graph Model; 2007 Jul; 26(1):226-35. PubMed ID: 17208024 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]